FDA Accepts for Review Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy for First-line Treatment of Advanced NSCLC

/PRNewswire/ -- Regulatory filing recently submitted in the European Union Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food...

Related Keywords

,Georged Yancopoulos ,Daren Kwok ,Vesna Tosic ,Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals Inc ,Twitter ,Regeneron Genetics Center ,Drug Administration ,Nasdaq ,Teva Pharmaceutical Industries Ltd ,Exchange Commission ,European Society For Medical Oncology Virtual Congress ,European Union ,European Medicines Agency ,Biologics License Application ,European Medicines ,European Society ,Medical Oncology Virtual Congress ,Chief Scientific Officer ,Prescribing Information ,Looking Statements ,Product Candidates ,Teva Pharmaceutical Industries ,Nc ,